Log in to post a reply
Feb 12, 2020 08:01AM
Venting for a minute - I'm extremely irritated!!!
My results for my mammogram and u/s on Jan 27th are now posted and the report is soooo scant (djmammo would be VERY disappointed!) and they do not reflect the conversation the Radiologist had with me AT ALL. She stated that the 2 masses "were probably benign" and she "recommended follow-up at 6 months". To which I raised my concerns and history and requested a biopsy. Here is what the report states:
ACR A: The breast tissue is almost entirely fatty.
2 faint tiny focal asymmetries in the area of concern in the upper outer right breast
Targeted sonographic evaluation was performed of the area of concern at 9:00 4 cm from nipple. There is a superficial hypoechoic parallel nodule measuring 3 x 3 mm. Chest 2 there is another 4.7 x 2.9 mm nodule. The appearance was discussed with the patient and her husband.
1. Patient is concerned about the 2 palpable lesions
2. Recommendation: Biopsy using ultrasound guidance for the larger deeper lesion
BI-RADS 4A (Biopsy recommended: low suspicion for malignancy).
At the end of the day, it doesn't change the fact that a biopsy has been performed and I'm waiting for the results now. However, I work in the medical field and it really upsets me that what she initially believed based on the imaging and her discussed with me is not what is now reflected in the medical record. It appears to me that she subjectively changed her initial medical opinion after our conversation, as opposed to evaluating the imaging and reporting her findings in an objective manner. GRRRR.
Dx at 43 (2018) with multi-focal IDC (1.7cm largest) + microinvasive DCIS 7.5 cm. LVI + Positive Anterior Margin for DCIS. Oncotype Score = 14. Local Recurrence February 2020
9/2018, DCIS/IDC, Right, Stage IA, Grade 2, 0/5 nodes, ER+/PR+, HER2-
10/11/2018 Mastectomy: Right; Reconstruction (right): DIEP flap
12/31/2018 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone)
2/2020, IDC, Right, <1cm, Grade 2, ER+/PR+, HER2- (IHC)
Femara (letrozole), Zoladex (goserelin)
Cytoxan (cyclophosphamide), Taxotere (docetaxel)